Natixis Merck & Co., Inc. Transaction History
Natixis
- $18 Billion
- Q1 2025
A detailed history of Natixis transactions in Merck & Co., Inc. stock. As of the latest transaction made, Natixis holds 1,453,078 shares of MRK stock, worth $112 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
1,453,078
Previous 349,625
315.61%
Holding current value
$112 Million
Previous $34.8 Million
275.01%
% of portfolio
0.73%
Previous 0.22%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,894Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$15.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.26 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.28 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.58 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...